$29.67
At close: Apr 16 EDT
$29.10
-0.57-1.92%
Pre-Market: 5:58 AM EDT
Comments
Loading...
Praxis Precision Medicine Analyst Ratings and Price Targets | NASDAQ:PRAX | Benzinga
Praxis Precision Medicine Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Praxis Precision Medicine Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Needham
Truist Securities
Baird
HC Wainwright & Co.
Deutsche Bank
1calculated from analyst ratings
Analyst Ratings for Praxis Precision Medicine
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/08/2025 | Buy Now | — | Needham | Ami Fadia50% | $85 → $85 | Reiterates | Buy → Buy | Get Alert |
| 03/03/2025 | Buy Now | — | Truist Securities | Joon Lee75% | $175 → $85 | Maintains | Buy | Get Alert |
| 03/03/2025 | Buy Now | — | Baird | Joel Beatty63% | $117 → $73 | Maintains | Outperform | Get Alert |
| 03/03/2025 | Buy Now | — | Needham | Ami Fadia50% | $150 → $85 | Maintains | Buy | Get Alert |
| 03/03/2025 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | $120 → $105 | Maintains | Buy | Get Alert |
| 02/11/2025 | Buy Now | — | Deutsche Bank | David Hoang34% | → $111 | Initiates | → Buy | Get Alert |
| 02/10/2025 | Buy Now | — | Needham | Ami Fadia50% | $150 → $150 | Reiterates | Buy → Buy | Get Alert |
| 01/21/2025 | Buy Now | — | Truist Securities | Joon Lee75% | $150 → $175 | Maintains | Buy | Get Alert |
| 12/12/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2024 | Buy Now | — | Needham | Ami Fadia50% | $151 → $151 | Reiterates | Buy → Buy | Get Alert |
| 10/31/2024 | Buy Now | — | Oppenheimer | Francois Brisebois39% | $143 → $163 | Maintains | Outperform | Get Alert |
| 09/10/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2024 | Buy Now | — | Needham | Ami Fadia50% | $151 → $151 | Reiterates | Buy → Buy | Get Alert |
| 09/04/2024 | Buy Now | — | Oppenheimer | Francois Brisebois39% | $134 → $143 | Reiterates | Outperform → Outperform | Get Alert |
| 09/04/2024 | Buy Now | — | Needham | Ami Fadia50% | $145 → $151 | Maintains | Buy | Get Alert |
| 09/03/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 09/03/2024 | Buy Now | — | Needham | Ami Fadia50% | $145 → $145 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | $105 → $120 | Maintains | Buy | Get Alert |
| 08/14/2024 | Buy Now | — | Wedbush | Laura Chico43% | $40 → $48 | Maintains | Neutral | Get Alert |
| 08/14/2024 | Buy Now | — | Oppenheimer | Francois Brisebois39% | $134 → $134 | Reiterates | Outperform → Outperform | Get Alert |
| 08/14/2024 | Buy Now | — | Guggenheim | Yatin Suneja46% | $155 → $170 | Maintains | Buy | Get Alert |
| 08/14/2024 | Buy Now | — | Needham | Ami Fadia50% | $145 → $145 | Reiterates | Buy → Buy | Get Alert |
| 08/12/2024 | Buy Now | — | Needham | Ami Fadia50% | $145 → $145 | Reiterates | Buy → Buy | Get Alert |
| 08/05/2024 | Buy Now | — | Oppenheimer | Francois Brisebois39% | → $134 | Initiates | → Outperform | Get Alert |
| 07/01/2024 | Buy Now | — | Piper Sandler | Yasmeen Rahimi50% | $270 → $270 | Maintains | Overweight | Get Alert |
| 06/24/2024 | Buy Now | — | Needham | Ami Fadia50% | → $145 | Initiates | → Buy | Get Alert |
| 06/18/2024 | Buy Now | — | Guggenheim | Yatin Suneja46% | → $155 | Initiates | → Buy | Get Alert |
| 05/16/2024 | Buy Now | — | Truist Securities | Joon Lee75% | $150 → $150 | Maintains | Buy | Get Alert |
| 05/14/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | $105 → $105 | Reiterates | Buy → Buy | Get Alert |
| 05/01/2024 | Buy Now | — | Baird | Joel Beatty63% | → $117 | Initiates | → Outperform | Get Alert |
| 04/26/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | $105 → $105 | Reiterates | Buy → Buy | Get Alert |
| 03/26/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | $105 → $105 | Reiterates | Buy → Buy | Get Alert |
| 03/26/2024 | Buy Now | — | Jefferies | Kambiz Yazdi44% | $75 → $128 | Maintains | Buy | Get Alert |
| 03/06/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | $105 → $105 | Reiterates | Buy → Buy | Get Alert |
| 01/12/2024 | Buy Now | — | Wedbush | Laura Chico43% | $16 → $29 | Maintains | Neutral | Get Alert |
| 12/05/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | → $105 | Reiterates | Buy → Buy | Get Alert |
| 12/04/2023 | Buy Now | — | Truist Securities | Joon Lee75% | → $150 | Reiterates | Buy → Buy | Get Alert |
| 11/15/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | → $105 | Reiterates | Buy → Buy | Get Alert |
| 10/03/2023 | Buy Now | — | Wedbush | Laura Chico43% | → $30 | Reiterates | Neutral → Neutral | Get Alert |
| 09/19/2023 | Buy Now | — | Truist Securities | Joon Lee75% | → $150 | Initiates | → Buy | Get Alert |
| 08/10/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | $225 → $105 | Maintains | Buy | Get Alert |
| 08/09/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | → $225 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2023 | Buy Now | — | Wedbush | Laura Chico43% | → $30 | Reiterates | Neutral → Neutral | Get Alert |
| 06/12/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | → $225 | Reiterates | Buy → Buy | Get Alert |
| 06/02/2023 | Buy Now | — | Jefferies | Kambiz Yazdi44% | → $60 | Initiates | → Buy | Get Alert |
| 05/12/2023 | Buy Now | — | Wedbush | Laura Chico43% | → $30 | Reiterates | → Neutral | Get Alert |
| 05/12/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | → $225 | Reiterates | Buy → Buy | Get Alert |
| 04/14/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | → $240 | Reiterates | → Buy | Get Alert |
| 03/06/2023 | Buy Now | — | William Blair | Myles Minter40% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 03/06/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | → $240 | Reiterates | → Buy | Get Alert |
| 02/08/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | → $240 | Reiterates | → Buy | Get Alert |
| 02/03/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | → $240 | Reiterates | → Buy | Get Alert |
| 06/08/2022 | Buy Now | — | Piper Sandler | Yasmeen Rahimi50% | $975 → $270 | Maintains | Overweight | Get Alert |
| 06/07/2022 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao49% | $720 → $150 | Maintains | Buy | Get Alert |
| 06/07/2022 | Buy Now | — | B of A Securities | Tazeen Ahmad55% | $390 → $60 | Downgrade | Buy → Neutral | Get Alert |
FAQ
What is the target price for Praxis Precision Medicine (PRAX) stock?
The latest price target for Praxis Precision Medicine (NASDAQ:PRAX) was reported by Needham on April 8, 2025. The analyst firm set a price target for $85.00 expecting PRAX to rise to within 12 months (a possible 192.10% upside). 32 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Praxis Precision Medicine (PRAX)?
The latest analyst rating for Praxis Precision Medicine (NASDAQ:PRAX) was provided by Needham, and Praxis Precision Medicine reiterated their buy rating.
When was the last upgrade for Praxis Precision Medicine (PRAX)?
There is no last upgrade for Praxis Precision Medicine
When was the last downgrade for Praxis Precision Medicine (PRAX)?
The last downgrade for Praxis Precision Medicines Inc happened on March 6, 2023 when William Blair changed their price target from N/A to N/A for Praxis Precision Medicines Inc.
When is the next analyst rating going to be posted or updated for Praxis Precision Medicine (PRAX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Praxis Precision Medicine, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Praxis Precision Medicine was filed on April 8, 2025 so you should expect the next rating to be made available sometime around April 8, 2026.
Is the Analyst Rating Praxis Precision Medicine (PRAX) correct?
While ratings are subjective and will change, the latest Praxis Precision Medicine (PRAX) rating was a reiterated with a price target of $85.00 to $85.00. The current price Praxis Precision Medicine (PRAX) is trading at is $29.10, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.